Clinical Trial Update: Clinical Evaluation of Injectable Alb-PRF in the Management of Intrabony Defect in Stage-III Periodontitis Patients [NA]

View source ↗

Summary

Clinical trial evaluating injectable Alb-PRF for intrabony defects in stage III periodontitis; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Alb-PRF injectable (Albumin Platelet Rich Fibrin (Alb-PRF))

Snippet

Sponsor: Cairo University | Conditions: Intrabony Periodontal Defect | NA | Status: NOT_YET_RECRUITING